BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7504063)

  • 1. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210.
    Nickowitz RE; Worman HJ
    J Exp Med; 1993 Dec; 178(6):2237-42. PubMed ID: 7504063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210.
    Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
    J Exp Med; 1995 Oct; 182(4):1159-62. PubMed ID: 7561689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.
    Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
    Hum Antibodies Hybridomas; 1996; 7(4):167-74. PubMed ID: 9140728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear envelope protein autoantibodies in primary biliary cirrhosis.
    Courvalin JC; Worman HJ
    Semin Liver Dis; 1997 Feb; 17(1):79-90. PubMed ID: 9089913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR.
    Lin F; Noyer CM; Ye Q; Courvalin JC; Worman HJ
    Hepatology; 1996 Jan; 23(1):57-61. PubMed ID: 8550049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.
    Courvalin JC; Lassoued K; Bartnik E; Blobel G; Wozniak RW
    J Clin Invest; 1990 Jul; 86(1):279-85. PubMed ID: 2195063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
    Itoh S; Ichida T; Yoshida T; Hayakawa A; Uchida M; Tashiro-Itoh T; Matsuda Y; Ishihara K; Asakura H
    J Gastroenterol Hepatol; 1998 Mar; 13(3):257-65. PubMed ID: 9570238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis.
    Nickowitz RE; Wozniak RW; Schaffner F; Worman HJ
    Gastroenterology; 1994 Jan; 106(1):193-9. PubMed ID: 8276182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis.
    Bandin O; Courvalin JC; Poupon R; Dubel L; Homberg JC; Johanet C
    Hepatology; 1996 May; 23(5):1020-4. PubMed ID: 8621127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of anti-nuclear envelope (gp210) antibody in primary biliary cirrhosis].
    Nakamura M
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):117-22. PubMed ID: 15997174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear antibodies specific for primary biliary cirrhosis.
    Worman HJ; Courvalin JC
    Autoimmun Rev; 2003 Jun; 2(4):211-7. PubMed ID: 12848948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis.
    Courvalin JC; Lassoued K; Worman HJ; Blobel G
    J Exp Med; 1990 Sep; 172(3):961-7. PubMed ID: 2167346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis.
    Shimoda S; Nakamura M; Ishibashi H; Kawano A; Kamihira T; Sakamoto N; Matsushita S; Tanaka A; Worman HJ; Gershwin ME; Harada M
    Gastroenterology; 2003 Jun; 124(7):1915-25. PubMed ID: 12806624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope.
    Tartakovsky F; Worman HJ
    Hepatology; 1995 Feb; 21(2):495-500. PubMed ID: 7531172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The single transmembrane segment of gp210 is sufficient for sorting to the pore membrane domain of the nuclear envelope.
    Wozniak RW; Blobel G
    J Cell Biol; 1992 Dec; 119(6):1441-9. PubMed ID: 1281815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis.
    Nakamura M; Takii Y; Ito M; Komori A; Yokoyama T; Shimizu-Yoshida Y; Koyabu M; Matsuyama M; Mori T; Kamihira T; Daikoku M; Migita K; Yatsuhashi H; Nozaki N; Shimoda S; Ishibashi H
    J Autoimmun; 2006 Mar; 26(2):138-45. PubMed ID: 16337775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study.
    Miyachi K; Hankins RW; Matsushima H; Kikuchi F; Inomata T; Horigome T; Shibata M; Onozuka Y; Ueno Y; Hashimoto E; Hayashi N; Shibuya A; Amaki S; Miyakawa H
    J Autoimmun; 2003 May; 20(3):247-54. PubMed ID: 12753810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis and the molecular cell biology of the nuclear envelope.
    Worman HJ
    Mt Sinai J Med; 1994 Nov; 61(6):461-75. PubMed ID: 7838161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.
    Xu J; Zhang H; Wang C; Jiang P; Han C; Dai Y; Qiu F; Gong Y; Jiang Y; Xu P; Zhang M; Zhang L; Shi X; Chen S; Tian Y; Seldin MF; Gershwin ME; Liu X; Li L
    J Immunol Methods; 2022 Feb; 501():113211. PubMed ID: 34971632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.